Potential impact of B cells on T cell function in MS
Posted: Fri Mar 25, 2011 7:41 am
Abstract
Multiple sclerosis is a chronic debilitating autoimmune disease of the central nervous system.
The contribution of B cells in the pathoetiology of MS has recently been highlighted by the emergence of rituximab, an anti-CD20 monoclonal antibody that specifically depletes B cells, as a potent immunomodulatory therapy for the treatment of MS.......... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... geid/1100/